Diagnostic performance of various imaging modalities in localizing ectopic ACTH syndrome: A systematic review
Annales d'Endocrinologie · 2024-12 · 85 (6) · 596-603
DOI: 10.1016/j.ando.2024.07.001 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Annales d'Endocrinologie, 2024-12. Verfasst von Chethan Yami Channaiah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Seth GS Medical College, KEM Hospital, 400012 Parel, Mumbai, India. Hauptthemen laut MEDLINE: ACTH Syndrome, Ectopic, Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 132 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: To elucidate the role of various imaging modalities for tumor localization in ectopic ACTH Cushing's syndrome (EAS). DESIGN AND METHOD: Systematic review of the literature published between January 2015-2024 was performed. Patients (290 EAS patients, 23.8% Occult) who underwent contrast enhanced CT (CECT) and at least one PET/CT-scan (68Ga-SSTR, FDG and/or F-DOPA) were included. RESULTS: The sensitivity for identifying EAS tumor was comparable across CECT (63.1%, n=290), SSTR-PET/CT (58.2%, n=187), and FDG-PET/CT (57.6%, n=191), but was poor for DOPA-PET/CT (30.8%, n=26). Sensitivity for detecting metastasis was also comparable across CECT (78%, n=73), SSTR-PET/CT (85.3%, n=41), and FDG-PET (73.7%, n=38). For localised lesions, sensitivity as per etiology and grade of NET were similar for three scans, with exception of Thymic NET and grade 1 NET where CECT was better than FDG PET/CT. In patients not localised on CECT, sensitivity of SSTR PET/CT was 33.3% (vs. 18.9% FDG-PET/CT) whereas for patients negative on CECT and FDG-PET, sensitivity of SSTR-PET/CT was 15%. In cases where CECT and SSTR-PET/CT failed to localize, the sensitivities of FDG-PET/CT and DOPA-PET/CT were only 5.7% (2/35) and 0% (0/9), respectively. SSTR-PET/CT has a distinct advantage with significantly lesser false positive (FP) lesions (2.6%, mostly in thyroid/or pancreas). In comparison, CECT and FDG-PET/CT had FP ∼11% (mostly in lung and/or mediastinum), most of which were negative on SSTR-PET/CT. CONCLUSIONS: As per the current evidence, SSTR-PET/CT can be considered as the scan of choice in EAS evaluation, and further research is needed as one-fourth of the lesions remain occult.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Seth GS Medical College, KEM Hospital, 400012 Parel, Mumbai, India.
- Department of Endocrinology, Vydehi Institute of Medical Sciences and Research Centre, 560066 Bengaluru, India.
- Radiation medical Centre, Bhabha Atomic Research Centre, 400012 Mumbai, India.
- Department of Endocrinology, Seth GS Medical College, KEM Hospital, 400012 Parel, Mumbai, India. Electronic address: drtusharb@gmail.com.
Zitieren
APA
Channaiah, C. Y., Memon, S. S., Lila, A. R., Sarathi, V., Karlekar, M., Barnabas, R., Patil, V. A., Sharma, A., Phadte, A., Malhotra, G., Shah, N., & Bandgar, T. (2024). Diagnostic performance of various imaging modalities in localizing ectopic ACTH syndrome: A systematic review. Annales d'Endocrinologie, 85(6), 596-603. https://doi.org/10.1016/j.ando.2024.07.001
Vancouver
Channaiah CY, Memon SS, Lila AR, Sarathi V, Karlekar M, Barnabas R, et al. Diagnostic performance of various imaging modalities in localizing ectopic ACTH syndrome: A systematic review. Annales d'Endocrinologie. 2024;85(6):596-603. doi:10.1016/j.ando.2024.07.001
BibTeX
@article{Channaiah2024,
author = {Channaiah, Chethan Yami and Memon, Saba Samad and Lila, Anurag Ranjan and Sarathi, Vijaya and Karlekar, Manjiri and Barnabas, Rohit and Patil, Virendra Ashokrao and Sharma, Anima and Phadte, Aditya and Malhotra, Gaurav and Shah, Nalini and Bandgar, Tushar},
title = {Diagnostic performance of various imaging modalities in localizing ectopic ACTH syndrome: A systematic review},
journal = {Annales d'Endocrinologie},
year = {2024},
volume = {85},
number = {6},
pages = {596--603},
doi = {10.1016/j.ando.2024.07.001}
}
EUVIMED